Factors Associated With Willingness to Receive a COVID-19 Vaccine Among 23,819 Adults Aged 50 Years or Older: An Analysis of the Canadian Longitudinal Study on Aging
Abstract Identifying persons who are least willing to receive a coronavirus disease 2019 (COVID-19) vaccine is critical for increasing uptake via targeted outreach. We conducted a survey of 23,819 Canadian Longitudinal Study on Aging participants from September 29 to December 29, 2020, to assess fac...
Saved in:
Published in | American journal of epidemiology Vol. 191; no. 6; pp. 987 - 998 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Oxford University Press
20.05.2022
Oxford Publishing Limited (England) |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Abstract
Identifying persons who are least willing to receive a coronavirus disease 2019 (COVID-19) vaccine is critical for increasing uptake via targeted outreach. We conducted a survey of 23,819 Canadian Longitudinal Study on Aging participants from September 29 to December 29, 2020, to assess factors associated with COVID-19 vaccination willingness and reasons for willingness or lack thereof. Among adults aged 50–96 years, 84.1% (95% confidence interval (CI): 83.7, 84.6) were very or somewhat willing to receive a COVID-19 vaccine; 15.9% (95% CI: 15.4, 16.3) were uncertain or very or somewhat unwilling. Based on logistic regression, those who were younger, female, had lower education and income, were non-White, and lived in a rural area were less willing to receive a COVID-19 vaccine. After controlling for these factors, recent receipt of influenza vaccine (adjusted odds ratio = 14.3, 95% CI: 12.5, 16.2) or planning to receive influenza vaccine (adjusted odds ratio = 10.5, 95% CI: 9.5, 11.6), as compared with no receipt or planning, was most strongly associated with COVID-19 vaccination willingness. Willingness was also associated with believing one had never been infected with severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) and experiencing negative pandemic consequences. Safety concerns were most common among those unwilling. Our comprehensive assessment of COVID-19 vaccination willingness among older adults in Canada, a prioritized group for vaccination due to their risk of severe COVID-19 outcomes, provides a road map for conducting outreach to increase uptake, which is urgently needed. |
---|---|
AbstractList | Identifying persons who are least willing to receive a coronavirus disease 2019 (COVID-19) vaccine is critical for increasing uptake via targeted outreach. We conducted a survey of 23,819 Canadian Longitudinal Study on Aging participants from September 29 to December 29, 2020, to assess factors associated with COVID-19 vaccination willingness and reasons for willingness or lack thereof. Among adults aged 50–96 years, 84.1% (95% confidence interval (CI): 83.7, 84.6) were very or somewhat willing to receive a COVID-19 vaccine; 15.9% (95% CI: 15.4, 16.3) were uncertain or very or somewhat unwilling. Based on logistic regression, those who were younger, female, had lower education and income, were non-White, and lived in a rural area were less willing to receive a COVID-19 vaccine. After controlling for these factors, recent receipt of influenza vaccine (adjusted odds ratio = 14.3, 95% CI: 12.5, 16.2) or planning to receive influenza vaccine (adjusted odds ratio = 10.5, 95% CI: 9.5, 11.6), as compared with no receipt or planning, was most strongly associated with COVID-19 vaccination willingness. Willingness was also associated with believing one had never been infected with severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) and experiencing negative pandemic consequences. Safety concerns were most common among those unwilling. Our comprehensive assessment of COVID-19 vaccination willingness among older adults in Canada, a prioritized group for vaccination due to their risk of severe COVID-19 outcomes, provides a road map for conducting outreach to increase uptake, which is urgently needed. Abstract Identifying persons who are least willing to receive a coronavirus disease 2019 (COVID-19) vaccine is critical for increasing uptake via targeted outreach. We conducted a survey of 23,819 Canadian Longitudinal Study on Aging participants from September 29 to December 29, 2020, to assess factors associated with COVID-19 vaccination willingness and reasons for willingness or lack thereof. Among adults aged 50–96 years, 84.1% (95% confidence interval (CI): 83.7, 84.6) were very or somewhat willing to receive a COVID-19 vaccine; 15.9% (95% CI: 15.4, 16.3) were uncertain or very or somewhat unwilling. Based on logistic regression, those who were younger, female, had lower education and income, were non-White, and lived in a rural area were less willing to receive a COVID-19 vaccine. After controlling for these factors, recent receipt of influenza vaccine (adjusted odds ratio = 14.3, 95% CI: 12.5, 16.2) or planning to receive influenza vaccine (adjusted odds ratio = 10.5, 95% CI: 9.5, 11.6), as compared with no receipt or planning, was most strongly associated with COVID-19 vaccination willingness. Willingness was also associated with believing one had never been infected with severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) and experiencing negative pandemic consequences. Safety concerns were most common among those unwilling. Our comprehensive assessment of COVID-19 vaccination willingness among older adults in Canada, a prioritized group for vaccination due to their risk of severe COVID-19 outcomes, provides a road map for conducting outreach to increase uptake, which is urgently needed. Identifying persons who are least willing to receive a coronavirus disease 2019 (COVID-19) vaccine is critical for increasing uptake via targeted outreach. We conducted a survey of 23,819 Canadian Longitudinal Study on Aging participants from September 29 to December 29, 2020, to assess factors associated with COVID-19 vaccination willingness and reasons for willingness or lack thereof. Among adults aged 50–96 years, 84.1% (95% confidence interval (CI): 83.7, 84.6) were very or somewhat willing to receive a COVID-19 vaccine; 15.9% (95% CI: 15.4, 16.3) were uncertain or very or somewhat unwilling. Based on logistic regression, those who were younger, female, had lower education and income, were non-White, and lived in a rural area were less willing to receive a COVID-19 vaccine. After controlling for these factors, recent receipt of influenza vaccine (adjusted odds ratio = 14.3, 95% CI: 12.5, 16.2) or planning to receive influenza vaccine (adjusted odds ratio = 10.5, 95% CI: 9.5, 11.6), as compared with no receipt or planning, was most strongly associated with COVID-19 vaccination willingness. Willingness was also associated with believing one had never been infected with severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) and experiencing negative pandemic consequences. Safety concerns were most common among those unwilling. Our comprehensive assessment of COVID-19 vaccination willingness among older adults in Canada, a prioritized group for vaccination due to their risk of severe COVID-19 outcomes, provides a road map for conducting outreach to increase uptake, which is urgently needed. Identifying persons who are least willing to receive a coronavirus disease 2019 (COVID-19) vaccine is critical for increasing uptake via targeted outreach. We conducted a survey of 23,819 Canadian Longitudinal Study on Aging participants from September 29 to December 29, 2020, to assess factors associated with COVID-19 vaccination willingness and reasons for willingness or lack thereof. Among adults aged 50-96 years, 84.1% (95% confidence interval (CI): 83.7, 84.6) were very or somewhat willing to receive a COVID-19 vaccine; 15.9% (95% CI: 15.4, 16.3) were uncertain or very or somewhat unwilling. Based on logistic regression, those who were younger, female, had lower education and income, were non-White, and lived in a rural area were less willing to receive a COVID-19 vaccine. After controlling for these factors, recent receipt of influenza vaccine (adjusted odds ratio = 14.3, 95% CI: 12.5, 16.2) or planning to receive influenza vaccine (adjusted odds ratio = 10.5, 95% CI: 9.5, 11.6), as compared with no receipt or planning, was most strongly associated with COVID-19 vaccination willingness. Willingness was also associated with believing one had never been infected with severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) and experiencing negative pandemic consequences. Safety concerns were most common among those unwilling. Our comprehensive assessment of COVID-19 vaccination willingness among older adults in Canada, a prioritized group for vaccination due to their risk of severe COVID-19 outcomes, provides a road map for conducting outreach to increase uptake, which is urgently needed.Identifying persons who are least willing to receive a coronavirus disease 2019 (COVID-19) vaccine is critical for increasing uptake via targeted outreach. We conducted a survey of 23,819 Canadian Longitudinal Study on Aging participants from September 29 to December 29, 2020, to assess factors associated with COVID-19 vaccination willingness and reasons for willingness or lack thereof. Among adults aged 50-96 years, 84.1% (95% confidence interval (CI): 83.7, 84.6) were very or somewhat willing to receive a COVID-19 vaccine; 15.9% (95% CI: 15.4, 16.3) were uncertain or very or somewhat unwilling. Based on logistic regression, those who were younger, female, had lower education and income, were non-White, and lived in a rural area were less willing to receive a COVID-19 vaccine. After controlling for these factors, recent receipt of influenza vaccine (adjusted odds ratio = 14.3, 95% CI: 12.5, 16.2) or planning to receive influenza vaccine (adjusted odds ratio = 10.5, 95% CI: 9.5, 11.6), as compared with no receipt or planning, was most strongly associated with COVID-19 vaccination willingness. Willingness was also associated with believing one had never been infected with severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) and experiencing negative pandemic consequences. Safety concerns were most common among those unwilling. Our comprehensive assessment of COVID-19 vaccination willingness among older adults in Canada, a prioritized group for vaccination due to their risk of severe COVID-19 outcomes, provides a road map for conducting outreach to increase uptake, which is urgently needed. |
Author | Thompson, Mary Kirkland, Susan Maimon, Geva Basta, Nicole E Sulis, Giorgia McMillan, Jacqueline M Sohel, Nazmul Raina, Parminder Griffith, Lauren E Wolfson, Christina |
Author_xml | – sequence: 1 givenname: Nicole E surname: Basta fullname: Basta, Nicole E – sequence: 2 givenname: Nazmul surname: Sohel fullname: Sohel, Nazmul – sequence: 3 givenname: Giorgia surname: Sulis fullname: Sulis, Giorgia – sequence: 4 givenname: Christina surname: Wolfson fullname: Wolfson, Christina – sequence: 5 givenname: Geva surname: Maimon fullname: Maimon, Geva – sequence: 6 givenname: Lauren E surname: Griffith fullname: Griffith, Lauren E – sequence: 7 givenname: Susan surname: Kirkland fullname: Kirkland, Susan – sequence: 8 givenname: Jacqueline M surname: McMillan fullname: McMillan, Jacqueline M – sequence: 9 givenname: Mary surname: Thompson fullname: Thompson, Mary – sequence: 10 givenname: Parminder surname: Raina fullname: Raina, Parminder email: praina@mcmaster.ca |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35166332$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kV1rFDEUhoNU7LZ65b0EBBF07Ekymd30Qhi2VgsLC35UvBoyyZnZrLPJOplp2R_k_zRl16JeCCE5nDw8nMN7Qo588EjIUwZvGChxptd49v1WG-DqAZmwfFpkBZfFEZkAAM8UL_gxOYlxDcCYkvCIHAvJikIIPiE_L7UZQh9pGWMwTg9o6Vc3rNLVdc63HmOkQ6Af0aC7QarpfHl9dZExRa-1Mc4jLTfBt5SL17PULO3YDcnWJo8E-g11coeeLjuL_TktfTq620WXug0dVkjn2mvrtKeLpHHDaF0C6KdU7GhIeJumeEweNrqL-OTwnpIvl-8-zz9ki-X7q3m5yEyew5DlLBcmbWmbxlou5cxKVYumlojcCICiFih5zTVYppTIEbBGpUHPJNQNoDglb_fe7Vhv0Br0Q6-7atu7je53VdCu-vvHu1XVhptqpkDkwJPg5UHQhx8jxqHauGiw67THMMYqZaFAKi6nCX3-D7oOY592v6OmcpZLUbBEvdpTpg8x9tjcD8Oguou_SvFXh_gT_ezP-e_Z33kn4MUeCOP2v6ZfHvW6ZQ |
CitedBy_id | crossref_primary_10_3389_fpubh_2023_1172642 crossref_primary_10_1136_bmjopen_2024_084560 crossref_primary_10_1186_s12879_024_09285_1 crossref_primary_10_2196_37887 crossref_primary_10_1371_journal_pone_0289541 crossref_primary_10_1007_s12062_023_09410_z crossref_primary_10_1016_j_vaccine_2024_02_045 crossref_primary_10_3390_vaccines10050732 crossref_primary_10_4236_ojim_2023_134036 crossref_primary_10_1016_j_vaccine_2021_11_088 crossref_primary_10_1002_jmv_28738 crossref_primary_10_1016_j_idc_2022_11_002 crossref_primary_10_1002_jmv_28156 crossref_primary_10_3389_fpubh_2022_1051035 crossref_primary_10_3390_vaccines11030542 crossref_primary_10_3390_vaccines10060966 crossref_primary_10_1016_j_pmedr_2023_102548 crossref_primary_10_17269_s41997_023_00746_9 crossref_primary_10_1002_nop2_1954 crossref_primary_10_1111_jep_13764 crossref_primary_10_3390_vaccines10101665 crossref_primary_10_3390_vaccines10040520 |
Cites_doi | 10.1073/pnas.2026322118 10.1017/S071498081500029X 10.1186/s12879-021-06023-9 10.1186/s12889-019-6567-x 10.1016/j.vaccine.2014.01.075 10.1007/s10654-020-00698-1 10.1080/13854046.2016.1254279 10.14745/ccdr.v42i12a02 10.1371/journal.pone.0251963 10.1001/jamahealthforum.2020.1539 10.1038/s41591-020-1124-9 10.1093/ije/dyz173 10.1016/j.vaccine.2018.05.037 10.1016/S0140-6736(21)00306-8 10.1073/pnas.2103700118 |
ContentType | Journal Article |
Copyright | The Author(s) 2022. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health 2022 The Author(s) 2022. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health. The Author(s) 2022. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health |
Copyright_xml | – notice: The Author(s) 2022. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health 2022 – notice: The Author(s) 2022. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health. – notice: The Author(s) 2022. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health |
CorporateAuthor | for the Canadian Longitudinal Study on Aging (CLSA) Research Team |
CorporateAuthor_xml | – name: for the Canadian Longitudinal Study on Aging (CLSA) Research Team |
DBID | TOX CGR CUY CVF ECM EIF NPM AAYXX CITATION 7QP 7T2 7TK 7U7 7U9 C1K H94 K9. NAPCQ 7X8 5PM |
DOI | 10.1093/aje/kwac029 |
DatabaseName | Open Access: Oxford University Press Open Journals Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Calcium & Calcified Tissue Abstracts Health and Safety Science Abstracts (Full archive) Neurosciences Abstracts Toxicology Abstracts Virology and AIDS Abstracts Environmental Sciences and Pollution Management AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Nursing & Allied Health Premium Virology and AIDS Abstracts Toxicology Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Health & Safety Science Abstracts Calcium & Calcified Tissue Abstracts Neurosciences Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitleList | Nursing & Allied Health Premium CrossRef MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: TOX name: Oxford University Press Open Access url: https://academic.oup.com/journals/ sourceTypes: Publisher |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Public Health |
EISSN | 1476-6256 |
EndPage | 998 |
ExternalDocumentID | 10_1093_aje_kwac029 35166332 10.1093/aje/kwac029 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | Canada |
GeographicLocations_xml | – name: Canada |
GrantInformation_xml | – fundername: CIHR |
GroupedDBID | --- -DZ -E4 -~X ..I .2P .55 .GJ .I3 .XZ .ZR 0R~ 186 1CY 1TH 23M 2WC 354 3O- 4.4 482 48X 53G 5GY 5RE 5VS 5WA 5WD 6.Y 6J9 70D 85S 8F7 AABZA AACZT AAJKP AAJQQ AAMVS AAOGV AAPGJ AAPNW AAPQZ AAPXW AAQQT AARHZ AASNB AAUAY AAUQX AAVAP AAWDT AAWTL AAYJJ ABEFU ABEUO ABIXL ABJNI ABKDP ABLJU ABNHQ ABNKS ABOCM ABPTD ABQLI ABQTQ ABSAR ABSMQ ABXVV ABZBJ ACFRR ACGFO ACGFS ACGOD ACMRT ACPQN ACPRK ACUFI ACUTJ ACUTO ACZBC ADBBV ADEYI ADEZT ADGZP ADHKW ADHZD ADIPN ADJQC ADOCK ADQBN ADRIX ADRTK ADVEK ADYVW ADZXQ AEGPL AEJOX AEKPW AEKSI AEMDU AENEX AENZO AEPUE AETBJ AEWNT AFFNX AFFZL AFIYH AFOFC AFRAH AFSHK AFXEN AFYAG AGINJ AGKEF AGKRT AGMDO AGSYK AHMBA AHXPO AI. AIAGR AIJHB AJEEA ALMA_UNASSIGNED_HOLDINGS ALUQC APIBT APJGH APWMN AQDSO AQKUS ASPBG ATGXG ATTQO AVNTJ AVWKF AXUDD AZFZN BAWUL BAYMD BCRHZ BEYMZ BHONS BTRTY BVRKM BZKNY C1A C45 CAG CDBKE COF CS3 CZ4 DAKXR DIK DILTD D~K E3Z EBS EE~ EIHJH EJD EMOBN F3I F5P F9B FEDTE FLUFQ FOEOM FOTVD FQBLK GAUVT GJXCC GX1 H13 H5~ HAR HVGLF HW0 HZ~ IH2 IOX J21 KAQDR KBUDW KC5 KOP KQ8 KSI KSN L7B M-Z M49 MBLQV ML0 N9A NEJ NGC NOMLY NOYVH NTWIH NU- NVLIB O0~ O9- OAWHX OCZFY ODMLO OHH OHT OJQWA OJZSN OK1 OPAEJ OVD OWPYF O~Y P2P P6G PAFKI PB- PEELM PQQKQ Q1. Q5Y QBD QZG R44 RD5 RHF RIG RNI ROL ROX ROZ RUSNO RW1 RXO RZF RZO TCURE TEORI TJX TMA TOX TR2 UAP UBC UHB UPT VH1 W8F WOQ X7H X7M YAYTL YF5 YKOAZ YOC YQI YROCO YSK YXANX Z0Y ZGI ZKX ZXP ~91 ADMHG CGR CUY CVF ECM EIF NPM AAYXX CITATION 7QP 7T2 7TK 7U7 7U9 C1K H94 K9. NAPCQ 7X8 5PM |
ID | FETCH-LOGICAL-c440t-4143c001dffdd2558d59b3fb5ee2c3006b3e52b2a0d19934e0ebe9a0a850bf0e3 |
IEDL.DBID | TOX |
ISSN | 0002-9262 1476-6256 |
IngestDate | Tue Sep 17 21:25:37 EDT 2024 Sat Oct 26 04:12:04 EDT 2024 Thu Oct 10 18:43:24 EDT 2024 Thu Sep 12 18:06:01 EDT 2024 Thu Oct 24 09:41:28 EDT 2024 Wed Aug 28 03:16:32 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Keywords | COVID-19 Canada SARS-CoV-2 Canadian Longitudinal Study on Aging vaccines coronavirus disease 2019 adults vaccination |
Language | English |
License | This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com The Author(s) 2022. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c440t-4143c001dffdd2558d59b3fb5ee2c3006b3e52b2a0d19934e0ebe9a0a850bf0e3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://dx.doi.org/10.1093/aje/kwac029 |
PMID | 35166332 |
PQID | 2675845361 |
PQPubID | 41038 |
PageCount | 12 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_8903402 proquest_miscellaneous_2629059257 proquest_journals_2675845361 crossref_primary_10_1093_aje_kwac029 pubmed_primary_35166332 oup_primary_10_1093_aje_kwac029 |
PublicationCentury | 2000 |
PublicationDate | 2022-05-20 |
PublicationDateYYYYMMDD | 2022-05-20 |
PublicationDate_xml | – month: 05 year: 2022 text: 2022-05-20 day: 20 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Oxford |
PublicationTitle | American journal of epidemiology |
PublicationTitleAlternate | Am J Epidemiol |
PublicationYear | 2022 |
Publisher | Oxford University Press Oxford Publishing Limited (England) |
Publisher_xml | – name: Oxford University Press – name: Oxford Publishing Limited (England) |
References | Lazarus (2022060609400315200_ref11) 2021; 27 Canadian Longitudinal Study on Aging (2022060609400315200_ref24) Goldstein (2022060609400315200_ref4) 2021; 118 World Health Organization (2022060609400315200_ref8) Malosh (2022060609400315200_ref26) 2014; 32 Ritchie (2022060609400315200_ref5) Logan (2022060609400315200_ref27) 2018; 36 Kelly (2022060609400315200_ref30) 2021; 21 Sakib (2022060609400315200_ref17) 2019; 19 Castro (2022060609400315200_ref3) 2021; 118 National Advisory Committee on Immunization, Public Health Agency of Canada (2022060609400315200_ref13) Canadian Longitudinal Study on Aging (2022060609400315200_ref23) 2020 Organisation for Economic Co-operation and Development (2022060609400315200_ref9) Canadian Longitudinal Study on Aging (2022060609400315200_ref19) 2020 Kirkland (2022060609400315200_ref16) 2015; 34 Dubé (2022060609400315200_ref25) 2016; 42 Wouters (2022060609400315200_ref7) 2021; 397 Levin (2022060609400315200_ref2) 2020; 35 Basta (2022060609400315200_ref1) Canadian Longitudinal Study on Aging (2022060609400315200_ref21) 2020 Canadian Longitudinal Study on Aging (2022060609400315200_ref20) 2020 Malani (2022060609400315200_ref29) 2020; 1 Frank (2022060609400315200_ref28) 2020 Ritchie (2022060609400315200_ref6) Nikolovski (2022060609400315200_ref31) 2021; 16 National Advisory Committee on Immunization, Public Health Agency of Canada (2022060609400315200_ref14) Statistics Canada (2022060609400315200_ref12) Public Health Agency of Canada (2022060609400315200_ref10) 2020 Raina (2022060609400315200_ref15) 2019; 48 Canadian Longitudinal Study on Aging (2022060609400315200_ref22) 2020 Tuokko (2022060609400315200_ref18) 2017; 31 |
References_xml | – ident: 2022060609400315200_ref14 contributor: fullname: National Advisory Committee on Immunization, Public Health Agency of Canada – volume-title: COVID-19 Questionnaire (Weekly) year: 2020 ident: 2022060609400315200_ref20 contributor: fullname: Canadian Longitudinal Study on Aging – volume: 118 issue: 11 year: 2021 ident: 2022060609400315200_ref4 article-title: Vaccinating the oldest against COVID-19 saves both the most lives and most years of life publication-title: Proc Natl Acad Sci U S A. doi: 10.1073/pnas.2026322118 contributor: fullname: Goldstein – volume: 34 start-page: 366 issue: 3 year: 2015 ident: 2022060609400315200_ref16 article-title: Mining a unique Canadian resource: the Canadian Longitudinal Study on Aging publication-title: Can J Aging. doi: 10.1017/S071498081500029X contributor: fullname: Kirkland – volume-title: COVID-19 Questionnaire (Baseline) year: 2020 ident: 2022060609400315200_ref19 contributor: fullname: Canadian Longitudinal Study on Aging – ident: 2022060609400315200_ref1 contributor: fullname: Basta – volume-title: Seasonal Influenza Vaccination Coverage in Canada, 2019–2020 year: 2020 ident: 2022060609400315200_ref10 contributor: fullname: Public Health Agency of Canada – volume: 21 start-page: 338 issue: 1 year: 2021 ident: 2022060609400315200_ref30 article-title: Predictors of willingness to get a COVID-19 vaccine in the U.S. publication-title: BMC Infect Dis. doi: 10.1186/s12879-021-06023-9 contributor: fullname: Kelly – volume: 19 start-page: 243 issue: 1 year: 2019 ident: 2022060609400315200_ref17 article-title: The prevalence of multimorbidity and associations with lifestyle factors among middle-aged Canadians: an analysis of Canadian Longitudinal Study on Aging data publication-title: BMC Public Health. doi: 10.1186/s12889-019-6567-x contributor: fullname: Sakib – volume: 32 start-page: 1841 issue: 16 year: 2014 ident: 2022060609400315200_ref26 article-title: Factors associated with influenza vaccine receipt in community dwelling adults and their children publication-title: Vaccine. doi: 10.1016/j.vaccine.2014.01.075 contributor: fullname: Malosh – volume: 35 start-page: 1123 issue: 12 year: 2020 ident: 2022060609400315200_ref2 article-title: Assessing the age specificity of infection fatality rates for COVID-19: systematic review, meta-analysis, and public policy implications publication-title: Eur J Epidemiol. doi: 10.1007/s10654-020-00698-1 contributor: fullname: Levin – volume: 31 start-page: 233 issue: 1 year: 2017 ident: 2022060609400315200_ref18 article-title: Cognitive measures in the Canadian Longitudinal Study on Aging publication-title: Clin Neuropsychol. doi: 10.1080/13854046.2016.1254279 contributor: fullname: Tuokko – year: 2020 ident: 2022060609400315200_ref21 contributor: fullname: Canadian Longitudinal Study on Aging – volume: 42 start-page: 246 issue: 12 year: 2016 ident: 2022060609400315200_ref25 article-title: Vaccine acceptance, hesitancy and refusal in Canada: challenges and potential approaches publication-title: Can Commun Dis Rep. doi: 10.14745/ccdr.v42i12a02 contributor: fullname: Dubé – volume: 16 issue: 5 year: 2021 ident: 2022060609400315200_ref31 article-title: Factors indicating intention to vaccinate with a COVID-19 vaccine among older U.S. adults publication-title: PloS One. doi: 10.1371/journal.pone.0251963 contributor: fullname: Nikolovski – ident: 2022060609400315200_ref5 contributor: fullname: Ritchie – volume: 1 issue: 12 year: 2020 ident: 2022060609400315200_ref29 article-title: Older adults’ perspectives on a COVID-19 vaccine publication-title: JAMA Health Forum. doi: 10.1001/jamahealthforum.2020.1539 contributor: fullname: Malani – ident: 2022060609400315200_ref8 contributor: fullname: World Health Organization – ident: 2022060609400315200_ref9 contributor: fullname: Organisation for Economic Co-operation and Development – volume: 27 start-page: 225 issue: 2 year: 2021 ident: 2022060609400315200_ref11 article-title: A global survey of potential acceptance of a COVID-19 vaccine publication-title: Nat Med. doi: 10.1038/s41591-020-1124-9 contributor: fullname: Lazarus – volume: 48 start-page: 1752 issue: 6 year: 2019 ident: 2022060609400315200_ref15 article-title: Cohort profile: the Canadian Longitudinal Study on Aging (CLSA) publication-title: Int J Epidemiol. doi: 10.1093/ije/dyz173 contributor: fullname: Raina – volume-title: COVID-19 Questionnaire (Exit) year: 2020 ident: 2022060609400315200_ref23 contributor: fullname: Canadian Longitudinal Study on Aging – ident: 2022060609400315200_ref6 contributor: fullname: Ritchie – ident: 2022060609400315200_ref24 contributor: fullname: Canadian Longitudinal Study on Aging – volume: 36 start-page: 4118 issue: 28 year: 2018 ident: 2022060609400315200_ref27 article-title: ‘What have you HEARD about the HERD?’ Does education about local influenza vaccination coverage and herd immunity affect willingness to vaccinate? publication-title: Vaccine. doi: 10.1016/j.vaccine.2018.05.037 contributor: fullname: Logan – ident: 2022060609400315200_ref12 contributor: fullname: Statistics Canada – ident: 2022060609400315200_ref13 contributor: fullname: National Advisory Committee on Immunization, Public Health Agency of Canada – volume: 397 start-page: 1023 issue: 10278 year: 2021 ident: 2022060609400315200_ref7 article-title: Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment publication-title: Lancet. doi: 10.1016/S0140-6736(21)00306-8 contributor: fullname: Wouters – year: 2020 ident: 2022060609400315200_ref22 contributor: fullname: Canadian Longitudinal Study on Aging – volume: 118 issue: 15 year: 2021 ident: 2022060609400315200_ref3 article-title: Prioritizing COVID-19 vaccination by age publication-title: Proc Natl Acad Sci U S A. doi: 10.1073/pnas.2103700118 contributor: fullname: Castro – volume-title: Canadians’ Willingness to Get a COVID-19 Vaccine: Group Differences and Reasons for Vaccine Hesitancy year: 2020 ident: 2022060609400315200_ref28 contributor: fullname: Frank |
SSID | ssj0011950 |
Score | 2.546132 |
Snippet | Abstract
Identifying persons who are least willing to receive a coronavirus disease 2019 (COVID-19) vaccine is critical for increasing uptake via targeted... Identifying persons who are least willing to receive a coronavirus disease 2019 (COVID-19) vaccine is critical for increasing uptake via targeted outreach. We... |
SourceID | pubmedcentral proquest crossref pubmed oup |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 987 |
SubjectTerms | Adults Aged Aging Canada - epidemiology Confidence intervals Coronaviruses COVID-19 - epidemiology COVID-19 - prevention & control COVID-19 Vaccines Cross-Sectional Studies Editor's Choice Female Humans Immunization Influenza Influenza Vaccines Longitudinal Studies Older people Original Contribution Pandemics Public health Rural areas SARS-CoV-2 Severe acute respiratory syndrome Severe acute respiratory syndrome coronavirus 2 Statistical analysis Vaccination Vaccines Viral diseases |
Title | Factors Associated With Willingness to Receive a COVID-19 Vaccine Among 23,819 Adults Aged 50 Years or Older: An Analysis of the Canadian Longitudinal Study on Aging |
URI | https://www.ncbi.nlm.nih.gov/pubmed/35166332 https://www.proquest.com/docview/2675845361 https://www.proquest.com/docview/2629059257 https://pubmed.ncbi.nlm.nih.gov/PMC8903402 |
Volume | 191 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1JT9wwFLYQB4RUIbZC2PqQeiTC8TKT9DaCjlg7F5bhFDmOzSYliMkI9Qf1f_a9STJiEGrPfnGivO2z38bYd4s-V0lrQ56rJFQx96Ex3ofOeu4knUjqBNlfnZNrdTbUwyZBdvRJCD-Rh-bJHT6_GcsF1ekhQiH9uxoMp8ECmmTaolxqf9eU4X14dsbxzBSzvcOUH1Mj3_ma_jJbakAi9GqurrA5V6yyhcsmDL7KvtSXbVDXEK2xP_16ag60P9vlcPtYPcDkNqW4J3MGVQmIER1aNzBwNLg5PQ6jBG6MpT2hR0OHQMgD9N3Qo6YcuNs97qM53KE2jKB8hQGN9P4BvQLaXiZQekAICW2TA7goaQDSOKdhW0BJir-hRHIahbTOrvs_r45Owmb-QmiV4lWoEEtZ_L-593mOR48410kmfaadE1aiumbSaZEJw3NKA1SOo0QkhptY84xY_ZXNF2XhNhl0XVfaSLpOxmOlnDIqSrzURmTWqy63AUpNw5z0pW6zkdbhcZkiD9OGhwH7hoz7N8VOy9S00cZRKuhUpLTsRAHbny6jHlFwxBSuHBONSBBqogUL2EYtA9P3SB0hMJMiYN0Z6ZgSUI_u2ZXi8WHSqztOuMQj-tZ_P3ybLQqqrOAaDdcOm69ex24X8U6V7SHSPz3fm8j8X4NY_nI |
link.rule.ids | 230,315,786,790,891,1611,27946,27947 |
linkProvider | Oxford University Press |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Factors+Associated+With+Willingness+to+Receive+a+COVID-19+Vaccine+Among+23%2C819+Adults+Aged+50+Years+or+Older%3A+An+Analysis+of+the+Canadian+Longitudinal+Study+on+Aging&rft.jtitle=American+journal+of+epidemiology&rft.au=Basta%2C+Nicole+E&rft.au=Sohel%2C+Nazmul&rft.au=Sulis%2C+Giorgia&rft.au=Wolfson%2C+Christina&rft.date=2022-05-20&rft.eissn=1476-6256&rft.volume=191&rft.issue=6&rft.spage=987&rft_id=info:doi/10.1093%2Faje%2Fkwac029&rft_id=info%3Apmid%2F35166332&rft.externalDocID=35166332 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0002-9262&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0002-9262&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0002-9262&client=summon |